期刊文献+

珠三角地区慢性HBV感染者未进行抗病毒治疗的原因分析及干预策略

Causative analysis of chronic HBV infected patients without antiviral therapy in the Pearl River Delta Region
下载PDF
导出
摘要 目的对慢性HBV感染者未进行抗病毒治疗的原因进行分析并探讨对策。方法对感染科门诊就医的慢性HBV感染者,自愿在门诊登记并长期随访,统计分析观察对象中未抗病毒治疗的主客观原因。结果 951例(男749例,女202例)患者中未行抗病毒治疗者共424例(男300例,女124例),其中未符合抗病毒治疗指征者319例(75.2%),符合抗病毒治疗指征者105例(24.8%),有指征而未抗病毒治疗的原因分别为:担心对生育影响49例(46.7%),经济困难31例(29.5%),顾虑不良反应或不确定疗程19例(18.1%),依从性差6例(5.7%);按性别比较,女性未抗病毒治疗的比例高于男性(61.4%vs 40.0%,P<0.001)。结论未符合抗病毒治疗指征是患者未进行抗病毒治疗的主要原因,而符合治疗指征而未进行抗病毒治疗的主要原因依次为生育困扰、经济困难、对安全性与疗效疗程不确定性的担忧、依从性差。干预策略:长期规范的随访和消除患者的疑虑是提高患者接受抗病毒治疗比例的有效措施。 Objective To investigate the reasons of the patients with chronic hepatitis B virus (HBV) infection without antiviral therapy and to explore its therapeutic strategies. Methods Long - termed observation on the out - patients with chronic HBV infection, who were voluntarily to be followed - up in clinic, was recruited for analysis of the objective and subjective causes of absence of antiviral therapy. Results Antiviral therapy was absent in 424 patients (300 male, 124 female) among total 951 patients (749 male, 202 female). Meanwhile, 105 patients (24. 8% ) was, while the other 319 patients (75.2%) was not, indicated for antiviral therapy. The reasons of those who had indications but did not receive antiviral therapy were as followed: worry about potential adverse effect on fertility (49 patients, 46. 7% ), unaffordability (31patients, 29. 5% ), side -effect of drugs or uncertainty of treatment duration (19/105, 18.1% ), and poor compliance (6/105, 5.7% ). The proportion of females not receiving antiviral therapy was significant higher than that of males (61.4% vs 40. 0%, P 〈 0. 001 ). Conclusion The lack of antiviral indication is the main reason in untreated group. The reasons of those with indications bat receive no antiviral therapy are followed by worry about harmful effect on fertility, unaffordability, side - effect of drugs or uncertainty of treatment duration, and poor compliance. Regular long - term follow - up and elimination of treatment anxiety would increase the proportion of patients with chronic HBV receiveing anti - HBV therapy.
出处 《广东医学》 CAS CSCD 北大核心 2011年第17期2254-2256,共3页 Guangdong Medical Journal
基金 国家"十一五"科技重大专项基金资助项目(编号:2009ZX10001-018)
关键词 抗病毒治疗 慢性乙型肝炎 随访 antiviral treatment chronic hepatitis B follow up
  • 相关文献

参考文献6

  • 1KEEFFE E B, DIETERICH D T, HANS H, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 Update[ J]. Clin Gastroenteml Hepatol, 2008, 6(12): 1315-1341. 被引量:1
  • 2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 3BUSTER E H, VAN ERPECUM K J, SCHALM S W, et al. Treatment of chronic hepatitis B virus infection [ J ]. Neth J Med, 2008, 66(7): 292-306. 被引量:1
  • 4VCEV A. Management of side effects during antiviral therapy [ J ]. Acta Med Croatica, 2009, 63 (5) : 463 -467. 被引量:1
  • 5MONDELLI M. New treatment options in chronic hepatitis B [ J ]. Infez Med, 2008, 16(1): 5-14. 被引量:1
  • 6张晓红,林国莉,朱建芸,陈黎,杨绍基,肖杰生.拉米夫定停药后慢性乙型肝炎复发的临床特点及相关因素[J].中华肝脏病杂志,2004,12(10):601-604. 被引量:7

二级参考文献28

共引文献1936

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部